Literature DB >> 10978577

Assessment of allodynia and hyperalgesia after cisplatin administration to rats.

N Authier1, J Fialip, A Eschalier, F Coudoré.   

Abstract

This work describes the behavioural responses of Sprague-Dawley rats to mechanical or thermal stimuli during and after administration of ten intraperitoneal injections of, alternatively, 1 and 2 mg/kg cisplatin every three days (cumulative dose: 15 mg/kg). Nociceptive signs including mechanical allodynia and hyperalgesia appeared after 3 and 6 cisplatin injections, respectively, and were maintained until 15 days after the last injection. The conservation of a good clinical status and fast appearance of symptoms are favourable criteria for using this animal model to understand the pathophysiological mechanisms implicated in the cisplatin-induced sensory peripheral neuropathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978577     DOI: 10.1016/s0304-3940(00)01373-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  The Effect of Anakinra on Paclitaxel-Induced Peripheral Neuropathic Pain in Rats.

Authors:  Ufuk Kuyrukluyıldız; İlke Küpeli; Zehra Bedir; Özgür Özmen; Didem Onk; Bahadır Süleyman; Renad Mammadov; Halis Süleyman
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-12-01

2.  Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.

Authors:  Victoria C J Wallace; Julie Blackbeard; Andrew R Segerdahl; Fauzia Hasnie; Timothy Pheby; Stephen B McMahon; Andrew S C Rice
Journal:  Brain       Date:  2007-08-30       Impact factor: 13.501

Review 3.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 4.  Animal models of chemotherapy-evoked painful peripheral neuropathies.

Authors:  Nicolas Authier; David Balayssac; Fabien Marchand; Bing Ling; Aude Zangarelli; Juliette Descoeur; François Coudore; Emmanuel Bourinet; Alain Eschalier
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

5.  Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.

Authors:  Josée Guindon; Yvonne Lai; Sara M Takacs; Heather B Bradshaw; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2012-11-02       Impact factor: 7.658

6.  Use of sodium bicarbonate to promote weight gain, maintain body temperature, normalize renal functions and minimize mortality in rodents receiving the chemotherapeutic agent cisplatin.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  Neurosci Lett       Date:  2013-04-06       Impact factor: 3.046

Review 7.  Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).

Authors:  Yaqin Han; Maree T Smith
Journal:  Front Pharmacol       Date:  2013-12-18       Impact factor: 5.810

8.  Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status.

Authors:  Josée Guindon; Liting Deng; Baochang Fan; Jim Wager-Miller; Andrea G Hohmann
Journal:  Mol Pain       Date:  2014-09-04       Impact factor: 3.395

9.  Effect of acute and chronic administration of carbamazepine on Cisplatin-induced hyperalgesia in rats.

Authors:  Alireza Mohajjel Nayebi; Hamdollah Sharifi; Mohammad Ramadzani; Hassan Rezazadeh
Journal:  Jundishapur J Nat Pharm Prod       Date:  2012-01-04

10.  Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

Authors:  Yoshihiro Seto; Fumiyasu Okazaki; Keiji Horikawa; Jing Zhang; Hitoshi Sasaki; Hideto To
Journal:  BMC Cancer       Date:  2016-09-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.